Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 34.63
+1.58 (4.78%)
At close: Jul 7, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 15.22 billion as of July 7, 2026. Its market cap has increased by 142.62% in one year.
Market Cap
15.22B
Enterprise Value
15.21B
Revenue
567.27M
Ranking
n/a
PE Ratio
69.26
Stock Price
34.63
Market Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 15.22B, an increase of 32,879.76%. That is a compound annual growth rate of 49.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 15.22B | -41.32% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 15.52B |
| Fredun Pharmaceuticals | 14.27B |
| Syncom Formulations (India) | 13.38B |
| TTK Healthcare | 13.00B |
| Lincoln Pharmaceuticals | 12.42B |
| Fermenta Biotech | 10.18B |
| Wanbury | 10.02B |
| Bharat Parenterals | 9.54B |